| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) | 
|---|
| 05/09/2007 | EP1781644A1 Macrocyclic beta-secretase inhibitors | 
| 05/09/2007 | EP1126855B1 Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons | 
| 05/09/2007 | CN1960970A Pyrrolidine derivatives as CB1-receptor antagonists | 
| 05/09/2007 | CN1958590A Derivative of oxazole p-camptothecin ester, preparation method and application | 
| 05/09/2007 | CN1958589A 6 (aryloxy methyl) ¿C 2 aryl ¿C 6, 7 dihydro 4H - pyrido [5,1 c ] [1,4] oxaxine ¿C 4 - ketone derivative, and preparation method | 
| 05/09/2007 | CN1314688C Pyridinebenzoxazine analog quinolone derivative and its preparation method and uses | 
| 05/08/2007 | US7214690 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers | 
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | 
| 05/08/2007 | US7214673 For therapy of psychosis and bipolar disorder | 
| 05/08/2007 | US7214538 fluoro or chromoionophore based on the covalent linkage of a fluoro or chromophore to an aza-crown-3 calix[4]arene ionophore; facilitating the treatment of various diseases, such as manic-depressive illness | 
| 05/03/2007 | WO2007050721A2 Heterocyclic aspartyl protease inhibitors | 
| 05/03/2007 | WO2007049675A1 Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase | 
| 05/03/2007 | WO2007048732A1 Use of 5-aminopyrazoles for controlling phytopathogenic harmful fungi, novel 5-aminopyrazoles, process for their preparation and composition comprising them | 
| 05/03/2007 | WO2007018998A3 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators | 
| 05/03/2007 | WO2007009007A3 Methods of treatment using hydroquinone ansamycins | 
| 05/03/2007 | US20070099976 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one, used for treating cellular proliferative disorders, nonproliferative degenerative disorders and viral diseases or infections | 
| 05/03/2007 | US20070099941 N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof | 
| 05/03/2007 | US20070099940 Pth agonists | 
| 05/03/2007 | US20070099904 Pharmaceutical composition for the treatment of cns and other disorders | 
| 05/03/2007 | US20070099898 2,4-benzodiazepine derivatives, used for treating cardiovascular diseases, cognitive and neurodegenerative diseases | 
| 05/03/2007 | US20070099897 Therapeutic compounds | 
| 05/03/2007 | US20070099894 e.g. 3-[(2,4-Difluorophenyl)amino]-2-{[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-7-phenylthieno[2,3-b]pyridin-6(7H)-one; autoimmune, neurodegenerative disorders, antiinflammatory agent; p38 MAP kinase inhibitor | 
| 05/03/2007 | US20070099877 N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof | 
| 05/03/2007 | US20070099848 Rapamycin carbohydrate derivatives | 
| 05/03/2007 | US20070099249 Compositions and liquid crystals | 
| 05/03/2007 | CA2626976A1 Heterocyclic aspartyl protease inhibitors | 
| 05/03/2007 | CA2626956A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity | 
| 05/02/2007 | EP1778696A2 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors | 
| 05/02/2007 | EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents | 
| 05/02/2007 | EP1592694B1 Active ingredient particles with clopidogrel or a pharmaceutically acceptable salt thereof | 
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa | 
| 05/02/2007 | CN1956722A Improved cytotoxic agents comprising new maytansinoids | 
| 05/02/2007 | CN1313470C Method for preparing N-methyl benzothiazole lifumeisu | 
| 05/01/2007 | CA2283587C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles | 
| 05/01/2007 | CA2188267C Use of tetrahydropteridine derivatives as no-synthase inhibitors | 
| 04/26/2007 | WO2007047207A2 5-lipoxygenase-activating protein (flap) inhibitors | 
| 04/26/2007 | WO2007046022A2 Inhibitors of phosphodiesterase type-iv | 
| 04/26/2007 | WO2007045876A1 Chromenones and their use as modulators of metabotropic glutamate receptors | 
| 04/26/2007 | WO2007045622A1 Oxazolo [4 , 5-b] pyridine compounds as nitric oxide synthase inhibitors | 
| 04/26/2007 | WO2007029082A3 An improved fermentation process for preparing ascomycin | 
| 04/26/2007 | WO2007025307A3 Inhibitors of serine proteases | 
| 04/26/2007 | WO2007023382A3 Pyrimidine amino pyrazole compounds, potent kinase inhibitors | 
| 04/26/2007 | US20070093658 used for the treatment of a cancer in mammals; anticarnogenic or antitumor agents | 
| 04/26/2007 | US20070093521 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives | 
| 04/26/2007 | US20070093509 Non-basic melanin concentrating hormone receptor-1 antagonists | 
| 04/26/2007 | US20070093508 Non-basic melanin concentrating hormone receptor-1 antagonists | 
| 04/26/2007 | US20070093498 Thieno-pyrimidine compounds having fungicidal activity | 
| 04/26/2007 | US20070093492 Pyrrolidine derivatives | 
| 04/26/2007 | US20070093482 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors | 
| 04/26/2007 | US20070093391 Weed control | 
| 04/26/2007 | CA2620248A1 Chromenones and their use as modulators of metabotropic glutamate receptors | 
| 04/25/2007 | EP1776370A1 Cci-779 derivatives and methods of making same | 
| 04/25/2007 | EP1776368A1 Inhibitors of hcv replication | 
| 04/25/2007 | EP1209151B1 4-substituted piperidine derivatives | 
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents | 
| 04/25/2007 | CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide | 
| 04/25/2007 | CN1312154C Purine derivatives as kinase inhibitors | 
| 04/25/2007 | CN1312136C Triazole derivatives as tachykinin receptor antagonists | 
| 04/25/2007 | CN1312131C Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent | 
| 04/24/2007 | US7208490 Having useful antibacterial activity against a wide range of human and veterinary pathogens; for therapy of microbial infections in mammals | 
| 04/24/2007 | US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling | 
| 04/24/2007 | CA2197793C New multimerizing agents | 
| 04/24/2007 | CA2171934C Endothelin receptor antagonists | 
| 04/24/2007 | CA2166811C Tricyclic inhibitors of the gpiibiiia receptor | 
| 04/19/2007 | WO2007044978A1 Method of tacrolimus extraction and quantification using aqueous detergents | 
| 04/19/2007 | WO2007044933A1 Hepatitis c virus inhibitors | 
| 04/19/2007 | WO2007044885A2 Piperidine derivatives and methods of use | 
| 04/19/2007 | WO2007044804A2 Piperidine derivatives and methods of use | 
| 04/19/2007 | WO2007042325A1 Antibacterial active 5-chinolin derivative | 
| 04/19/2007 | WO2007000325A3 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-on- compounds and the use thereof for producing drugs | 
| 04/19/2007 | WO2006101217A3 Luminous compound containing lanthanide ion | 
| 04/19/2007 | US20070088159 Hydroxyalkyl cyclic diamine compounds | 
| 04/19/2007 | US20070088059 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases | 
| 04/19/2007 | US20070088049 Polymorphic forms of methyl (+)-(s) - alpha - (2-chlorophenyl)-6, 7-dihydrothieno [3,2-c]pyridine-5(4h) acetate hydrobromide, clopidogrel hydrobromide | 
| 04/19/2007 | US20070088048 Clopidogrel salt and polymorphic forms thereof | 
| 04/19/2007 | US20070088036 1-[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carbonitrile; -[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carboxylic acid methyl ester; deposited on a stent or stent-graft device | 
| 04/19/2007 | US20070088025 Tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives as cannabinoid cb1 receptor agonists | 
| 04/19/2007 | CA2625687A1 Antibacterial active 5-chinolin derivative | 
| 04/19/2007 | CA2625649A1 Method of tacrolimus extraction and quantification using aqueous detergents | 
| 04/18/2007 | EP1773844A1 Compounds having affinity for the dopamine d3 receptor and uses thereof in medicine | 
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders | 
| 04/18/2007 | EP1773346A1 Substituted quinobenzoxazine analogs and methods of using thereof | 
| 04/18/2007 | EP1773343A1 Antibacterial agents | 
| 04/18/2007 | EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | 
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators | 
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors | 
| 04/18/2007 | CN1950380A (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors | 
| 04/18/2007 | CN1950378A Thienopyridazines as ikk inhibitors | 
| 04/18/2007 | CN1950377A Thienopyridines as IKK inhibitors | 
| 04/18/2007 | CN1948315A Tricycle compounds and its application in making medicine | 
| 04/18/2007 | CN1310922C Fused bicyclic pyridine derivative as tachykinin receptor antagonist | 
| 04/18/2007 | CN1310919C 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof | 
| 04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators | 
| 04/17/2007 | US7205408 Therapy for bacteria infections in mammals | 
| 04/17/2007 | US7205334 vacuolar-type (H+)-ATPase-inhibiting macrocyclic lactams belonging to the chondropsin class useful in cancer chemotherapy | 
| 04/17/2007 | US7205300 Aryl fused azapolycyclic compounds | 
| 04/17/2007 | US7205295 such as 4-(4-tert-Butyl-benzyl)-6-(4-oxo-2-thioxo-thiazolidin-5-ylidenemethyl)-4H-1,4-benzoxazin-3-one; phosphoinositide-3-kinases (PI3Ks); for treatment/prevention of inflammatory diseases, cardiovascular diseases, and cancers | 
| 04/17/2007 | CA2350073C Ccr5 modulators | 
| 04/17/2007 | CA2124260C Tetrahydropyran derivatives | 
| 04/12/2007 | WO2007041052A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |